Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARATANA THERAPEUTICS, INC. | 2,345,543 | reported | 15 Jul 2015 | tx 10+3,975,674−7,533,333 |
| AKESIS PHARMACEUTICALS, INC. | 1,500,000 | reported | 13 Jun 2008 | tx 3+1,000,000−500,000 |
| Otonomy, Inc. | 27,500 | reported | 21 Jun 2022 | tx 68+2,822,252−4,547,225 |
| Janux Therapeutics, Inc. | 11,308 | reported | 13 Sept 2024 | tx 29+9,594,078−7,787,996 |
| Synthorx, Inc. | 0 | reported | 23 Jan 2020 | tx 18+6,737,547−16,054,653 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 391 | 39.80 USD | |
| 13 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 778 | 13.22 USD | |
| 13 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 778 | 10.73 USD | |
| 13 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 1,868 | 17.00 USD | |
| 13 Sept 2024 | SALE | Janux Therapeutics, Inc. | 3,815 | 46.68 USD | |
| 13 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 1,868 | 0.00 USD | deriv |
| 13 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 778 | 0.00 USD | deriv |
| 13 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 778 | 0.00 USD | deriv |
| 13 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 391 | 0.00 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 2,500 | 0.00 USD | |
| 26 Jun 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 8,350 | 0.00 USD | deriv |
| 03 Jun 2024 | SALE | Janux Therapeutics, Inc. | 677,279 | 54.75 USD | anomaly |
| 03 Jun 2024 | SALE | Janux Therapeutics, Inc. | 131,196 | 54.75 USD | |
| 03 Jun 2024 | SALE | Janux Therapeutics, Inc. | 691,525 | 54.75 USD | anomaly |
| 13 Nov 2023 | PURCHASE | Janux Therapeutics, Inc. | 849,854 | 5.87 USD | first after silence |
| 14 Jun 2023 | GRANT_AWARD | Janux Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 21 Jun 2022 | GRANT_AWARD | Otonomy, Inc. | 27,500 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | Janux Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 22 Jun 2021 | GRANT_AWARD | Otonomy, Inc. | 17,500 | 0.00 USD | deriv |
| 15 Jun 2021 | CONVERSION | Janux Therapeutics, Inc. | 2,382,191 | — | |
| 15 Jun 2021 | PURCHASE | Janux Therapeutics, Inc. | 629,411 | 17.00 USD | first after silence |
| 15 Jun 2021 | CONVERSION | Janux Therapeutics, Inc. | 1,153,238 | — | |
| 15 Jun 2021 | CONVERSION | Janux Therapeutics, Inc. | 2,696,843 | — | |
| 15 Jun 2021 | CONVERSION | Janux Therapeutics, Inc. | 674,211 | — | |
| 15 Jun 2021 | CONVERSION | Janux Therapeutics, Inc. | 1,138,665 | — |
4 purchases reported after at least 12 months of silence — most recent on 13 Nov 2023.